FDA Inspection
GlaxoSmithKline Biologicals SAGlaxoSmithKline Biologicals SA – FDA Inspection, Jun 24, 2019
Record Details
This FDA Inspection record concerns GlaxoSmithKline Biologicals SA, with an inspection on June 24, 2019, issued by the Office of Inspections and Investigations, covering biologics.
- People
- Debra M. Emerson (FDA Associated Person)
- Leslie D. Wagner (Issuing Officer)
- Shuang Tang (Issuing Officer)
- Susan M. Jackson (Issuing Officer)
View Company Profile
ID · c59f4d26-ddd7-4e65-b71c-2b9e086c0932
Inspection Facts
- Inspection number
- 1099401
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of GlaxoSmithKline Biologicals SA
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 27, 2026 | Not classified | Office of Inspections and Investigations | Vaccine, Allergenic, and Live Biotherapeutic Products |
| June 23, 2023 | Not classified | Office of Inspections and Investigations |
Other documents for GlaxoSmithKline Biologicals SA
- FDA Inspection 1305486 - 2026-02-27
- FDA Inspection 1214970 - 2023-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.